| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. | Director | Stock Option (right to buy) | 17.5K | Jun 2, 2025 | Direct | ||
| Atreca, Inc. | Director | Stock Option (right to buy) | 12K | Jun 13, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | Jun 2, 2025 | 1 | $0 | 4 | Jun 3, 2025 | Director |
| ORKA | Oruka Therapeutics, Inc. | Aug 29, 2024 | 0 | $0 | 3 | Sep 6, 2024 | Director |
| BCEL | Atreca, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| BCEL | Atreca, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| BCEL | Atreca, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 11, 2021 | Director |